Abstract
Neostigmine is a clinical cholinesterase inhibitor, that is, commonly used to enhance the function of the cholinergic neuromuscular junction. Recent studies have shown that neostigmine regulates the immune-inflammatory response through the cholinergic anti-inflammatory pathway, affecting perioperative neurocognitive function. This article reviews the relevant research evidence over the past 20years, intending to provide new perspectives and strategies for the clinical application of neostigmine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have